You are here: Industry Insights > Merck

News List

As Merck cans another hepatitis C project, can leader Gilead capitalize? fiercepharma
September 30, 2017
These days, hep C isn’t looking like the cash cow market it once was, prompting some of those trailing behind leader Gilead to bail on their development programs.
Merck Discontinues MK-3682B and MK-3682C Development Programs americanpharmaceuticacreview
September 30, 2017
Remarkable progress has been made in the fight against hepatitis C infection, and Merck is enormously proud of the role we have had in that fight over the past 30 years
Merck opens Bio-development centre in Shanghai biospectrumasia
September 26, 2017
The Shanghai center is designed to meet the specific needs of customers in the APAC region.
Pfizer, Merck KGaA grab EU approval for PD-L1 Bavencio in Merkel cell carcinoma fiercepharma
September 22, 2017
Pfizer and Merck KGaA’s new immuno-oncology drug Bavencio, which won an FDA nod for Merkel cell carcinoma in March, is now approved in Europe to treat the aggressive type of skin cancer.
Merck’s MS pill Mavenclad launched in the UK and Ireland pharmatimes
September 22, 2017
Merck’s Mavenclad is now available in the UK and Ireland to treat highly active relapsing multiple sclerosis in adults.
Merck and Pfizer's joint skin cancer drug gets EU approval pharmafile
September 22, 2017
Merck KGaA and Pfizer have announced that European authorisation of their jointly developed drug Bavencio (avelumab) as a monotherapy in the treatment of metastatic Merkel cell carcinoma (mMCC), a rare and aggressive skin cancer.
Merck Announces Recipients of the Grant for Growth Innovation 2017 prnasia
September 18, 2017
Merck, a leading science and technology company today announced the recipients of the Grant for Growth Innovation (GGI) for 2017.
Clinical trial matching platform raises $11M backed by Merck’s tech fund fiercebiotech
September 14, 2017
Antidote, as one of them, just recently raised $11 million in a financing round led by Merck Global Health Innovation (GHI) Fund.
Merck announces findings from Phase III study of KEYTRUDA expressbpd
September 14, 2017
The findings include updated survival data showing a 19 per cent reduction in the risk of death over standard treatment in the intent-to-treat population
Merck, Project Data Sphere to pioneer Global Oncology Big Data Alliance pharmaasia
September 14, 2017
Merck and Project Data Sphere big data platform to help accelerate innovative discovery, development and delivery of new approaches in cancer care.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 51 52 Next page